• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型单纯疱疹病毒缺失变异体1714和1716确定了格拉斯哥17 +株中位于即刻早期基因1和“a”序列之间的神经毒力相关序列。

Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence.

作者信息

MacLean A R, ul-Fareed M, Robertson L, Harland J, Brown S M

机构信息

MRC Virology Unit, Institute of Virology, Glasgow, U.K.

出版信息

J Gen Virol. 1991 Mar;72 ( Pt 3):631-9. doi: 10.1099/0022-1317-72-3-631.

DOI:10.1099/0022-1317-72-3-631
PMID:1848598
Abstract

Dideoxynucleotide sequence analysis of a spontaneously isolated deletion variant (1714) of Glasgow strain 17+ of herpes simplex virus type 1 (HSV-1) demonstrates that the deletion is 759 bp in length and is located within each copy of the BamHI s fragment (0 to 0.02 and 0.81 to 0.83 map units) of the long repeat region of the genome. The deletion removes one complete copy of the 18 bp DR1 element of the 'a' sequence and terminates 1105 bp upstream of the 5' end of immediate early (IE) gene 1. The variant grows to high titre, is not temperature-sensitive and is not host cell type-restricted in vitro. In vivo studies demonstrate that 1714 is totally avirulent for BALB/c mice following intracerebral inoculation, with an LD50 of 7 x 10(6) p.f.u./mouse compared to less than 10 p.f.u./mouse for the parental wild-type strain 17+. In vivo growth kinetics show that the non-neurovirulent phenotype is due to an inability to replicate in mouse brain. Because 1714 was in a genomic background in which the four XbaI sites had been removed and because the phenotype was thymidine kinase-negative, the 759 bp deletion was introduced into an otherwise totally wild-type background. The resulting variant (1716) is non-neurovirulent for mice, with an LD50 of 7 x 10(6) p.f.u./mouse. The deletion does not prevent the virus from establishing a latent infection or reactivating from it in vitro. The results demonstrate that sequences between IE-1 and the 'a' sequence produce neurovirulence in Glasgow strain 17+ and, in conjunction with the non-neurovirulence of the HSV-2 HG52 variant JH2604, identify a common function conserved in HSV-1 and -2.

摘要

对单纯疱疹病毒1型(HSV-1)格拉斯哥17+株自发分离的缺失变异体(1714)进行双脱氧核苷酸序列分析表明,该缺失长度为759 bp,位于基因组长重复区域BamHI s片段(0至0.02和0.81至0.83图谱单位)的每个拷贝内。该缺失去除了“a”序列中18 bp DR1元件的一个完整拷贝,并在立即早期(IE)基因1的5'端上游1105 bp处终止。该变异体生长至高效价,对温度不敏感,在体外不受宿主细胞类型限制。体内研究表明,1714经脑内接种后对BALB/c小鼠完全无毒,半数致死剂量(LD50)为7×10(6) 蚀斑形成单位/小鼠,而亲本野生型毒株17+的LD50小于10蚀斑形成单位/小鼠。体内生长动力学表明,非神经毒力表型是由于无法在小鼠脑中复制。由于1714处于已去除四个XbaI位点的基因组背景中,且表型为胸苷激酶阴性,因此将759 bp缺失引入到其他方面完全为野生型的背景中。所得变异体(1716)对小鼠无神经毒力,LD50为7×10(6) 蚀斑形成单位/小鼠。该缺失并不妨碍病毒在体外建立潜伏感染或从中重新激活。结果表明,IE-1和“a”序列之间的序列在格拉斯哥17+株中产生神经毒力,并与HSV-2 HG52变异体JH2604的非神经毒力相结合,确定了HSV-1和-2中保守的共同功能。

相似文献

1
Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence.1型单纯疱疹病毒缺失变异体1714和1716确定了格拉斯哥17 +株中位于即刻早期基因1和“a”序列之间的神经毒力相关序列。
J Gen Virol. 1991 Mar;72 ( Pt 3):631-9. doi: 10.1099/0022-1317-72-3-631.
2
The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency.单纯疱疹病毒2型HG52株中的RL神经毒力位点在潜伏过程中不起作用。
J Gen Virol. 1991 Sep;72 ( Pt 9):2305-10. doi: 10.1099/0022-1317-72-9-2305.
3
The herpes simplex virus type 2 (HG52) variant JH2604 has a 1488 bp deletion which eliminates neurovirulence in mice.2型单纯疱疹病毒(HG52)变体JH2604有一个1488碱基对的缺失,该缺失消除了其在小鼠中的神经毒力。
J Gen Virol. 1989 Nov;70 ( Pt 11):3073-8. doi: 10.1099/0022-1317-70-11-3073.
4
Abolition of the RL neurovirulence phenotype of herpes simplex virus type 2 strain HG52 does not require deletion of the DR1 element of the 'a' sequence.单纯疱疹病毒2型HG52株的RL神经毒力表型的消除并不需要缺失“a”序列的DR1元件。
J Gen Virol. 1991 Nov;72 ( Pt 11):2777-9. doi: 10.1099/0022-1317-72-11-2777.
5
A variant of herpes simplex virus type 2 strain HG52 with a 1.5 kb deletion in RL between 0 to 0.02 and 0.81 to 0.83 map units is non-neurovirulent for mice.单纯疱疹病毒2型HG52毒株的一个变体,其RL区在0至0.02和0.81至0.83图谱单位之间有1.5 kb的缺失,对小鼠无神经毒性。
J Gen Virol. 1989 Mar;70 ( Pt 3):705-16. doi: 10.1099/0022-1317-70-3-705.
6
The JH2604 deletion variant of herpes simplex virus type 2 (HG52) fails to produce necrotizing encephalitis following intracranial inoculation of mice.单纯疱疹病毒2型(HG52)的JH2604缺失变异株在小鼠颅内接种后不会引发坏死性脑炎。
J Gen Virol. 1990 Jul;71 ( Pt 7):1597-601. doi: 10.1099/0022-1317-71-7-1597.
7
Localization of a herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain.一种与大脑中高滴度病毒复制无关的单纯疱疹病毒神经毒力基因的定位。
J Virol. 1988 Apr;62(4):1381-7. doi: 10.1128/JVI.62.4.1381-1387.1988.
8
Herpes simplex virus neurovirulence and productive infection of neural cells is associated with a function which maps between 0.82 and 0.832 map units on the HSV genome.单纯疱疹病毒的神经毒性及在神经细胞中的增殖性感染与位于单纯疱疹病毒基因组上0.82至0.832图谱单位之间的一个功能区相关。
Virology. 1989 Oct;172(2):435-50. doi: 10.1016/0042-6822(89)90186-4.
9
Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence.脑内接种1型单纯疱疹病毒(KOS株)诱导成年小鼠脑炎的特征及与毒力降低突变株的比较
Lab Invest. 1989 Jun;60(6):822-30.
10
HSV-1 virulence for mice by the intracerebral route is encoded by the BamHI-L DNA fragment containing the cell fusion gene.单纯疱疹病毒1型经脑内途径对小鼠的毒力由包含细胞融合基因的BamHI-L DNA片段编码。
Arch Virol. 1987;96(1-2):117-22. doi: 10.1007/BF01310995.

引用本文的文献

1
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.髓调节治疗增强了溶瘤病毒免疫治疗在恶性外周神经鞘瘤小鼠模型中的治疗效益。
Front Immunol. 2024 Jun 25;15:1384623. doi: 10.3389/fimmu.2024.1384623. eCollection 2024.
2
Towards a comprehensive view of the herpes B virus.迈向全面认识单纯疱疹 B 病毒
Front Immunol. 2023 Nov 16;14:1281384. doi: 10.3389/fimmu.2023.1281384. eCollection 2023.
3
Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma.
溶瘤单纯疱疹病毒和腺病毒治疗复发性脑胶质瘤的研究进展。
Front Immunol. 2023 Nov 2;14:1285113. doi: 10.3389/fimmu.2023.1285113. eCollection 2023.
4
Blank Spots in the Map of Human Skin: The Challenge for Xenotransplantation.人体皮肤图谱中的空白:异种移植面临的挑战。
Int J Mol Sci. 2023 Aug 14;24(16):12769. doi: 10.3390/ijms241612769.
5
Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells.溶瘤单纯疱疹病毒治疗脑胶质瘤和靶向脑胶质瘤干细胞。
Front Cell Infect Microbiol. 2023 May 31;13:1206111. doi: 10.3389/fcimb.2023.1206111. eCollection 2023.
6
HSV Replication: Triggering and Repressing STING Functionality.HSV 复制:触发和抑制 STING 功能。
Viruses. 2023 Jan 13;15(1):226. doi: 10.3390/v15010226.
7
Persistent inflammation and neuronal loss in the mouse brain induced by a modified form of attenuated herpes simplex virus type I.经改良的Ⅰ型单纯疱疹病毒在小鼠大脑中引起的持续炎症和神经元缺失。
Virol Sin. 2023 Feb;38(1):108-118. doi: 10.1016/j.virs.2022.11.008. Epub 2022 Nov 24.
8
Advances in immunotherapy for glioblastoma multiforme.胶质母细胞瘤的免疫治疗进展。
Front Immunol. 2022 Oct 12;13:944452. doi: 10.3389/fimmu.2022.944452. eCollection 2022.
9
Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers.单纯疱疹病毒1作为难治性癌症的溶瘤病毒疗法。
Front Oncol. 2022 Jul 27;12:940019. doi: 10.3389/fonc.2022.940019. eCollection 2022.
10
The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1.单纯疱疹病毒 1 型在芬兰循环株的体外复制、传播和溶瘤潜力。
Viruses. 2022 Jun 13;14(6):1290. doi: 10.3390/v14061290.